High Provider Volume is Associated with Lower Rate of Secondary Therapies after Definitive Radiotherapy for Localized Prostate Cancer

European Urology

Volumn 54, Issue 1, 2008, Pages 97-106

  Jeldres, Claudio ^a,b   Suardi, Nazareno ^a,c   Saad, Fred ^b   Montorsi, Francesco ^c   Shariat, Shahrokh F ^d   Perrotte, Paul ^b   Bhojani, Naeem ^a,b   Walz, Jochen ^a,e   Hutterer, Georg C ^a,f   Graefen, Markus ^g   Valiquette, Luc ^b   Karakiewicz, Pierre I ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

^g Martini Clinic Prostate Cancer Center   (Germany)

Author keywords

Prostate cancer; Provider volume; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; COHORT ANALYSIS; COMORBIDITY; COVARIANCE; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER;

AGED; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; QUEBEC; RADIOTHERAPY;

EID: 44049086671     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.10.070     Document Type: Article

References (31)

1. Kitahata M.M., Koepsell T.D., Deyo R.A., et al. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med 334 (1996) 701-706
2. Birkmeyer J.D., Siewers A.E., Finlayson E.V., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 346 (2002) 1128-1137
3. Casale P.N., Jones J.L., Wolf F.E., Pei Y., and Eby L.M. Patients treated by cardiologists have a lower in-hospital mortality for acute myocardial infarction. J Am Coll Cardiol 32 (1998) 885-889
4. McGrath P.D., Wennberg D.E., Dickens Jr. J.D., et al. Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. JAMA 284 (2000) 3139-3144
5. Taylor H.D., Dennis D.A., and Crane H.S. Relationship between mortality rates and hospital patient volume for Medicare patients undergoing major orthopaedic surgery of the hip, knee, spine, and femur. J Arthroplasty 12 (1997) 235-242
6. Hillner B.E., Smith T.J., and Desch C.E. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol 18 (2000) 2327-2340
7. Halm E.A., Lee C., and Chassin M.R. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med 137 (2002) 511-520
8. Ellison L.M., Heaney J.A., and Birkmeyer J.D. The effect of hospital volume on mortality and resource use after radical prostatectomy. J Urol 163 (2000) 867-869
9. Ellison L.M., Trock B.J., Poe N.R., and Partin A.W. The effect of hospital volume on cancer control after radical prostatectomy. J Urol 173 (2005) 2094-2098
10. Hu J.C., Gold K.F., Pashos C.L., Mehta S.S., and Litwin M.S. Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol 21 (2003) 401-405
11. Lu-Yao G.L., McLerran D., Wasson J., and Wennberg J.E. An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. JAMA 269 (1993) 2633-2636
12. Konety B.R., Allareddy V., Modak S., and Smith B. Mortality after major surgery for urologic cancers in specialized urology hospitals: are they any better?. J Clin Oncol 24 (2006) 2006-2012
13. Lee W.R., deGuzman A.F., Bare R.L., Marshall M.G., and McCullough D.L. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution. Int J Radiat Oncol Biol Phys 46 (2000) 83-88
14. Merrick G.S., Grimm P.D., Sylvester J., et al. Initial analysis of Pro-Qura: a multi-institutional database of prostate brachytherapy dosimetry. Brachytherapy 6 (2007) 9-15
15. Keyes M., Schellenberg D., Moravan V., et al. Decline in urinary retention incidence in 805 patients after prostate brachytherapy: the effect of learning curve?. Int J Radiat Oncol Biol Phys 64 (2006) 825-834
16. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
17. Ramsey E.W., Elhilali M., Goldenberg S.L., et al. Practice patterns of Canadian urologists in benign prostatic hyperplasia and prostate cancer. Canadian Prostate Health Council. J Urol 163 (2000) 499-502
18. D'Hoore W., Sicotte C., and Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med 32 (1993) 382-387
19. Mazumdar M., and Glassman J.R. Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments. Stat Med 19 (2000) 113-132
20. Bennett C.L., Adams J., Gertler P., et al. Relation between hospital experience and in-hospital mortality for patients with AIDS-related Pneumocystis carinii pneumonia: experience from 3,126 cases in New York City in 1987. J Acquir Immune Defic Syndr 5 (1992) 856-864
21. Cunningham W.E., Tisnado D.M., Lui H.H., Nakazono T.T., and Carlisle D.M. The effect of hospital experience on mortality among patients hospitalized with acquired immunodeficiency syndrome in California. Am J Med 107 (1999) 137-143
22. Hogg R.S., Raboud J., Bigham M., et al. Relation between hospital HIV/AIDS caseload and mortality among persons with HIV/AIDS in Canada. Clin Invest Med 21 (1998) 27-32
23. Farley D.E., and Ozminkowski R.J. Volume-outcome relationships and in-hospital mortality: the effect of changes in volume over time. Med Care 30 (1992) 77-94
24. Thiemann D.R., Coresh J., Oetgen W.J., and Powe N.R. The association between hospital volume and survival after acute myocardial infarction in elderly patients. N Engl J Med 340 (1999) 1640-1648
25. D'Amico A.V., Schultz D., Loffredo M., et al. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer. JAMA 284 (2000) 1280-1283
26. Hoinkis C., Hakenberg O.W., Lehmann D., et al. Evaluation of dose-volume histograms after prostate seed implantation. 4-year experience. Strahlenther Onkol 180 (2004) 550-556
27. Acher P.L., Morris S.L., Popert R.J., et al. Permanent prostate brachytherapy: a century of technical evolution. Prostate Cancer Prostatic Dis 9 (2006) 215-220
28. Vickers A.J., Bianco F.J., Serio A.M., et al. The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst 99 (2007) 1171-1177
29. Katz S.J., Hofer T.P., Hawley S., et al. Patterns and correlates of patient referral to surgeons for treatment of breast cancer. J Clin Oncol 25 (2007) 271-276
30. Walz J., Gallina A., Hutterer G., et al. Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 69 (2007) 88-94
31. Alibhai S.M., Naglie G., Nam R., Trachtenberg J., and Krahn M.D. Do older men benefit from curative therapy of localized prostate cancer?. J Clin Oncol 21 (2003) 3318-3327